Antidepressant drug studies, 1964 to 1986: Empirical evidence for aging patients

Journal of Clinical Psychopharmacology

Volumn 8, Issue 5, 1988, Pages 311-322

  Gerson, Sylvia C ^a   Plotkin, Daniel A ^a,b   Jarvik, Lissy F ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CHLORDIAZEPOXIDE; DOXEPIN; FLUOXETINE; IMIPRAMINE; LITHIUM; MAPROTILINE; MIANSERIN; NOMIFENSINE; NORTRIPTYLINE; PHENELZINE; PROCAINE; TRAZODONE; TRIMIPRAMINE; VILOXAZINE;

AGED; DEPRESSION; HUMAN; PSYCHOLOGICAL ASPECT; REVIEW; SIDE EFFECT;

AGED; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; DEPRESSIVE DISORDER; HUMAN; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0023794839     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: None     Document Type: Article

References (139)

1. Mintz J, Steuer J, Jarvik LF. Psychotherapy with depressed elderly patients: research considerations. J Consult Clin Psychol 1981;49:542–8.
2. Weissman M, Myers J. Depression in the elderly: research directions in psychopathology, epidemiology and treatment. J. Geriatr Psychiatry 1979;12:187–201.
3. Zung WWK, Gianturco D, Pfeiffer E, Wang HS, Whanger A, Bridge P, Potkin SJ. Pharmacology of depression in the aged: evaluation of Gerovital-H3 as an antidepressant drug. Psychosomatics 1974;15:127–31.
4. Weissman MM, Prusoff BA, Sholomskas AJ, Berry C. The pharmacologic treatment of the depressed elderly: a pilot study of alprazolam (Xanax TM), imipramine (Tofranil) or placebo. In: Burrows GD, Norman TR, Maguire KP, eds. Biological psychiatry: recent studies. London: John Libbey, 1984:167–74.
5. Friedel RO. The effects of age on the pharmacology of tricyclic antidepressants. In: Raskin A, Robinson DS, Levine J, eds. Age and the pharmacology of psychoactive drugs. New York: Elsevier/North-Holland, 1981:125–31.
6. Stotsky B. Psychoactive drugs for geriatric patients with psychiatric disorders. In: Gershon S, Raskin A, eds. Aging, vol 2. New York: Raven Press, 1975:220–58.
7. Gerner R, Estabrook W, Steuer J, Jarvik L. Treatment of geriatric depression with trazodone, imipramine and placebo: a double-blind study. J Clin Psychiatry 1980;41:216–20.
8. Jarvik L., Mintz J, Steuer J, Gerner, R. Treating geriatric depression: a 26-week interim analysis. J Am Geriatr Soc 1982;30:713–7.
9. Cohn JB, Varga L, Lyford A. A two center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients. J Clin Psychiatry 1984;45(4, sec 2):68–72.
10. Merideth CH, Feighner JP, Hendrickson G. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients. J Clin Psychiatry 1984;45(4, sec 2):73–7.
11. Branconnier RJ, Cole JO, Ghazvinian S, Spera KF, Oxenkrug GF, Bass JL. Clinical pharmacology of bupropion and imipramine in elderly depressives. J Clin Psychiatry 1983;44:130–3.
12. Kane JM, Cole K, Sarantakos S, Howard A, Borenstein M. Safety and efficacy of bupropion in elderly patients: preliminary observations. J Clin Psychiatry 1983;44(5, sec 2):134–6.
13. Neshkes RE, Gerner R, Jarvik L., Mintz J, Joseph J, Linde S, Aldrich J, Conolly ME, Rosen R, Hill M. Orthostatic effect of imipramine and doxepin in depressed geriatric outpatients. J Clin Psychopharmacol 1985;5:102–6.
14. Ayd FJ. Long term administration of doxepin. Dis Nerv Syst 1971;32:627–62.
15. Ban TA. Treatment of depressed geriatric patients. Am J Psychother 1978;32:93–104.
16. Davies G, Burrows G, Dumovic P, Vohra J, Hunt D, Sloman G, Scoggins B. Effects on the heart of different tricyclic antidepressants. In: Mendel J, ed. Sinequan, a monograph of recent clinical studies. Amsterdam: Excerpta Medica, 1975:54–8.
17. Ahles S, Gwirtsman H, Halaris A, Shah P, Schwarcz G, Hill MA. Comparative cardiac effects of maprotiline and doxepin in elderly depressed patients. J Clin Psychiatry 1984;45:460–5.
18. Feighner J, Hendrickson G, Miller L, Stern W. Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder. J Clin Psychopharmacol 1986;6:27–32.
19. Jarvik L., Mintz J. Treatment of depression in old age: what works? In: Awad AG, Durost EB, McCormick WO, Meier EMR, eds. Disturbed behavior in the elderly. New York: Pergamon Press, 1987:51–7.
20. Lakshmanan M, Mion LC, Frengley JD. Effective low dose tricyclic antidepressant treatment for depressed geriatric rehabilitation patients: a double-blind study. J Am Geriatr Soc 1986;34:421–6.
21. Baldessarini RJ. Antidepressant agents. In: Baldessarini RJ, ed. Chemotherapy in psychiatry. Cambridge, MA: Harvard University Press, 1977:75–125.
22. Raskin A. Psychopharmacology of depression in the elderly. Annual Review of Gerontology Geriatrics 1982;3:266–96.
23. Gwirtsman HE, Ahles S, Halaris A, DeMet E, Hill MA. Therapeutic superiority of maprotiline versus doxepin in geriatric depression. J Clin Psychiatry 1983;44:449–53.
24. Feighner JP, Cohn JB. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry 1985;46 (3, sec 2):20–5.
25. Assalian P, Rosengarten MD, Phillips R. A comparative trial of the antidepressant, anxiolytic, and cardiovascular effects of trimipramine and doxepin in depressed hospitalized patients. J Clin Psychiatry 1985;46:90–4.
26. Luchins J. Review of clinical and animal studies comparing the cardiovascular effects of doxepin and other tricyclic antidepressants. Am J Psychiatry 1983;140:1006–9.
27. Salzman C, van der Kolk B. Treatment of depression. In: Salzman C, ed. Clinical geriatric psychopharmacology. New York: McGraw-Hill. 1985:77–115.
28. Branconnier RJ, Cole JO, Ghazvinian S, Rosenthal S. Treating the depressed elderly patient: the comparative behavioral pharmacology of mianserin and amitriptyline. In: Costa E, Racagni G, eds. Typical and atypical antidepressants: clinical practice. New York: Raven Press, 1982:195–212.
29. Cassem NH. Cardiovascular effects of antidepressants. J Clin Psychiatry 1982;43(11, sec 2):22–8.
30. Settle EC, Ayd FJ. Trimipramine: twenty years’ worldwide clinical experience. J Clin Psychiatry 1980;41:266–74.
31. Janowsky DS, Byerley B. Desipramine: an overview. J Clin Psychiatry 1984;45(10, sec 2):3–7.
32. Nelson JC, Jatlow PI, Mazure C. Desipramine plasma levels and response in elderly melancholic patients. J Clin Psychopharmacol 1985;5:217–20.
33. Cutler NR, Zavadil AP, Eisdorfer C, Ross RJ, Potter WZ. Concentrations of desipramine in elderly women. Am J Psychiatry 1981;138:1235–7.
34. Cutler NR, Zavadil AP, Linnoila M, Scheinin M, Rudorfer MV, Potter WZ. Effects of chronic desipramine on plasma norepinephrine concentrations and cardiovascular parameters in elderly depressed women: a preliminary report. Biol Psychiatry 1984;19:549–56.
35. Antal EJ, Lawson IR, Alderson LM, Chapron DJ, Kramer PA. Estimating steady state desipramine levels in noninstitutionalized elderly patients using single dose disposition parameters. J Clin Psychopharmacol 1982;2:193–8.
36. Young RC, Alexopoulos GS, Shamoian CA, Manley MW, Dhar AK, Kutt H. Therapeutic response to nortriptyline in the elderly (abstract). Proceedings of the American Psychiatric Association Annual Meeting 1982:210.
37. Young RC, Alexopoulos GS, Manley MW, Shamoian CA, Dhar AK, Kutt H. Treatment outcome in elderly depressives: plasma nortriptyline concentration and pretreatment dexamethasone suppression test. In: Usdin E, Åsberg M, Bertilsson L, Sjöqvist R, eds. Frontiers in biochemical and pharmacological research in depression. New York: Raven Press, 1984:207–11.
38. Kernohan WJ, Chambers JL, Wilson WT, Daugherty JF. Effects of nortriptyline on the mental and social adjustment of geriatric patients in a mental hospital. J Am Geriatr Soc 1967;15:196–202.
39. Chesrow EJ, Kaplitz SE, Breme JT, Sabatini R, Vetra H, Marquardt GH. Nortriptyline for the treatment of anxiety and depression in chronically ill and geriatric patients. J Am Geriatr Soc 1964;12:271–7.
40. Brodie NH, McGhie RL, O’Hara H, Valle-Jones JC, Schiff AA. Anxiety/depression in elderly patients. A double-blind comparative study of fluphenezine/nortriptyline and promazine. Practitioner 1975;215:660–4.
41. Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TP. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1984;1:297–300.
42. Schneider LS, Sloane RB, Staples FR, Bender M. Pretreatment orthostatic hypotension as a predictor of response to nortriptyline in geriatric depression. J Clin Psychopharmacol 1986;6:172–6.
43. Rubin EH, Biggs JT, Preskorn SH. Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice. J Clin Psychiatry 1985;46:418–24.
44. Dawling S, Crome IP, Braithwaite RA, Lewis RR. Nortriptyline therapy in elderly patients: dosage prediction after single dose pharmacokinetic study. Eur J Clin Pharmacol 1980;18:147–50.
45. Boyer WF, Lake CR. Initial severity and diagnosis influence the relationship of tricyclic plasma levels to response: a statistical review. J Clin Psychopharmacol 1987;7:67–71.
46. Bertilsson L, Mellstrom B, Sjöqvist F. Pronounced inhibition of noradrenaline uptake by 10-hydroxymetabolites of nortriptyline. Life Sci 1979;25:1285–92.
47. Roose SP, Glassman AH, Giardina EV, Johnson LL, Walsh BT, Woodring S, Bigger JT. Nortriptyline in depressed patients with left ventricular impairment. JAMA 1986;256:3253–7.
48. Young RC, Alexopoulos GS, Shamoian CA, Dhar AK, Kutt H. Heart failure associated with high plasma 10-hydroxy-nortriptyline levels. Am J Psychiatry 1984;141:432–3.
49. Gelenberg AJ, Wojcik JD, Lydiard RB, McCormick MGF, Falk WE, Hicks RH, Curren FC, Cohen BM. Double-blind comparison of amoxapine and imipramine in the treatment of depressed patients. J Clin Psychiatry 1984;45:54–9.
50. Giannini AJ, Price WA. Amoxapine-induced seizures: case reports. J Clin Psychiatry 1984;45:358–9.
51. Litovitz TL, Troutman WG. Amoxapine overdose: seizures and fatalities. JAMA 1983;250:1069–71.
52. Kulig K. Cyclic antidepressant overdose. J Clin Psychiatry Monogr 1985;3:19–23.
53. Alkalay D, Wagner WE, Carisen S, Khemani L, Volk J Jr, Bartlett MF, LeSher A. Bioavailability and kinetics of maprotiline. Clin Pharmacol Ther 1980;27:697–703.
54. Rudorfer MV, Golden RN, Potter WZ. Second generation antidepressants. Psychiatr Clin North Am 1984;7:519–34.
55. Robinson DS. Adverse reactions, toxicities and drug interactions of newer antidepressants: anticholinergic, sedative, and other side effects. Psychopharmacol Bull 1984;20:280–90.
56. Pecknold JC, Familamiri P, McClure DJ, Elie R, Chang H. Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison. J Clin Psychiatry 1985;46:166–71.
57. Edwards JG, Goldie A. Mianserin, maprotiline, and intracardiac conduction. Br J Pharmacol 1983;15(suppl):249–54.
58. Glassman AH. The newer antidepressant drugs and their cardiovascular effects. Psychopharmacol Bull 1984;20:272–9.
59. Crome P, Newman B. Fatal tricyclic antidepressant poisoning. J R Soc Med 1979;72:649–53.
60. Glassman AH, Bigger JT Jr. Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Arch Gen Psychiatry 1981; 38:815–20.
61. Riblet LA, Taylor DP. Pharmacology and neurochemistry of trazodone. J Clin Psychopharmacol 1981;1(suppl):17–22.
62. Shopsin B, Cassano GB, Conti L. An overview of new “second generation” antidepressant compounds: research and treatment implications. In: Enna SJ, Malick JB, Richelson E, eds. Antidepressants: neurochemical, behavioral and clinical perspectives. New York: Raven Press, 1981:219–51.
63. Burns M, Moskowitz H, Jaffe J. A comparison of the effects of trazodone and amitriptyline on skills performance by geriatric subjects. J Clin Psychiatry 1986;47:252–4.
64. Klein HE, Müller N. Trazodone in endogenous depressed patients: a negative report and a critical evaluation of the pertaining literature. Prog Neuropsychopharmacol Biol Psychiatry 1985;9:173–86.
65. Simpson DM, Foster D. Improvement in organically disturbed behavior with trazodone treatment. J Clin Psychiatry 1986;47: 191–3.
66. Scardigli G, Jans G. Comparative double-blind study on efficacy and side-effects of trazodone, nomifensine, and mianserin in elderly patients. In: Costa E, Racagni G, eds. Typical and atypical antidepressants: clinical practice. New York: Raven Press, 1982: 229–37.
67. Stark P, Hardison CD. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry 1985;46(3, sec 2):53–8.
68. Cohn JB, Wilcox C. A comparison of fluoxetine, imipramine and placebo in patients with major depressive disorder. J Clin Psychiatry 1985;46(3, sec 2):26–31.
69. Feighner JP. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. J Clin Psychiatry 1985;46:369–72.
70. van Praag HM. In search of the mode of action of antidepressants 5-HTP/tyrosine mixture in depression. Neuropharmacology 1983;22:433–40.
71. Alexopoulos GS, Lieberman KW, Young RC, Shamoian CA. Platelet MAO activity and age at onset of depression in elderly depressed women. Am J Psychiatry 1984;141:1276–8.
72. Robinson DS, Davis JM, Nies A, Ravaris CL, Sylvester D. Relation of sex and aging to monoamine oxidase activity of human brain, plasma, and platelets. Arch Gen Psychiatry 1971;24:536–9.
73. Pare CMB. The present status of monoamine oxidase inhibitors. Br J Psychiatry 1985;146:576–84.
74. Goldman LS, Alexander RC, Luchins DJ. Monoamine oxidase inhibitors and tricyclic antidepressants: comparison of their cardiovascular effects. J Clin Psychiatry 1986;47:225–9.
75. Georgotas A, Kim OM, Hapworth W, Bow AD, Friedman E. Monoamine oxidase inhibitors and affective disorders in the elderly. Psychopharmacol Bull 1983;19:662–5.
76. Roose SP, Glassman AH, Walsh BT, Woodring S. Tricyclic nonresponders: phenomenology and treatment. Am J Psychiatry 1986;143:345–8.
77. Georgotas A, McCue RE, Hapworth W, Friedman E, Kim OM, Welkowitz J, Chang I, Cooper TB. Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly. Biol Psychiatry 1986;21:1155–66.
78. Kushnir SL. Lithium-antidepressant combinations in the treatment of depressed, physically ill geriatric patients. Am J Psychiatry 1986;143:3–4.
79. Price LH, Charney DS, Heninger GR. Efficacy of lithium-tranylcypromine treatment in refractory depression. Am J Psychiatry 1985;142:619–23.
80. Pande AD, Max P. A lithium tricyclic combination for treatment of depression (letter). Am J Psychiatry 1985;142:1228–9.
81. Abou-Saleh MT, Coppen A. The prognosis of depression in old age: the case for lithium therapy (letter). Br J Psychiatry 1983; 143:527–8.
82. Murray N, Hopwood S, Balfour DJK, Ogston S, Hewick DS. The influence of age on lithium efficacy and side-effects in out-patients. Psychol Med 1983;13:53–60.
83. Shulman K, Post F. Bipolar affective disorder in old age. Br J Psychiatry 1980;136:26–32.
84. Hewick DS, Newbury P, Hopwood S, Naylor G, Moody J. Age as a factor affecting lithium therapy. J Clin Pharmacol 1977;4:201–5.
85. Jefferson JW. Lithium and affective disorder in the elderly. Compr Psychiatry 1983;24:166–78.
86. Himmelhoch JM, Neil JF, May SJ, Fuchs CZ, Licata SM. Age, dementia, dyskinesias, and lithium response. Am J Psychiatry 1980:137:941–5.
87. Corcoran AC, Taylor RD, Page IH. Lithium poisoning from the use of salt substitutes. JAMA 1949;139:685–8.
88. Johnson G, Maccario M, Gershon S, Korein J. The effects of lithium on electroencephalogram, behavior, and serum electrolytes. J Nerv Ment Dis 1970;151:273–89.
89. Shopsin B, Johnson G, Gershon S. Neurotoxicity with lithium: differential drug responsiveness. Int Pharmacopsychiatry 1970; 5:170–82.
90. Greil W, Stoltzenburg MC, Mairhofer ML, Haag M. Lithium dosage in the elderly—a study with matched age groups. J Affective Disord 1985;9:1–4.
91. Jansen W, Siegfried K. Nomifensine in geriatric inpatients: a placebo-controlled study. J Clin Psychiatry 1984;45(4, sec 2):63–7.
92. Goldstein SE, Birnbom F, Laliberte R. Nomifensine in the treatment of depressed geriatric patients. J Clin Psychiatry 1982; 43:287–9.
93. Schönhöfer PS, Gröticke J. Fatal necrotising vasculitis associated with nomifensine. Lancet 1985;2:221.
94. Levy AB, Davis J, Bidder TG. Successful treatment of endogenous depression with alprazolam in a patient with recent cardiac disease: case report. J Clin Psychiatry 1984;45:480–1.
95. Greenblatt DJ, Shader RI. Benzodiazepines. N Engl J Med 1972;291:1239–43.
96. Feighner JP, Aden GC, Fabre LF, Rickles K, Smith WT. Comparison of alprazolam, imipramine, and placebo in the treatment of depression. JAMA 1983;249:3057–64.
97. Feighner JP. Benzodiazepines as antidepressants. Mod Probl Pharmacopsychiatry 1982;18:196–212.
98. Beber CR. Treating anxiety and depression in the elderly: a double-blind crossover evaluation of two widely used tranquilizers. J Fla Med Assoc 1971;58:35–8.
99. Jacobson A. The use of Ritalin in psychotherapy of depression of the aged. Psvchiatr Q 1958;32:474–85.
100. Katon W, Raskind M. Treatment of depression in the medically ill elderly with methylphenidate. Am J Psychiatry 1980;137: 963–5.
101. Kaufmann MW, Murray GB, Cassem NH. Use of psychostimulants in medically ill depressed patients. Psychosomatics 1982;23:817–9.
102. Landman ME, Preisig R, Perlman M. A practical mood stimulant. Journal of the Medical Society of New Jersey 1958;55:55–8.
103. Shader RI, Kennedy JS. Geriatric psychiatry: biological treatments. In: Kaplan E, Sadock B, eds. Comprehensive textbook of psychiatry, 5th ed. Baltimore: Williams & Wilkins, in press.
104. Robertson MM, Trimble MR. Major tranquillisers used as antidepressants. J Affective Disord 1982;4:173–93.
105. Thompson W. General practitioner clinical trials: thioridazine as an antidepressant. Practitioner 1972;209:95–8.
106. Kettering RL, Harrow M, Grossman L, Meltzer HY. The prognostic relevance of delusions in depression: a follow-up study. Am J Psychiatry 1987;144:1154–60.
107. Spiker DG, Weiss JC, Dealy RS, Griffin SJ, Hanin I, Neil JF, Perel J, Rossi AJ, Soloff PH. The pharmacological treatment of delusional depression. Am J Psychiatry 1985;142:430–6.
108. Perry PJ, Morgan DE, Smith RE, Tsuang MT. Treatment of unipolar depression accompanied by delusions. J Affective Disord 1982;4:195–200.
109. Meyers BS, Kalayam B, Mei-tal V. Late-onset delusional depression: a distinct clinical entity? J Clin Psychiatry 1984;45:347–9.
110. Meyers BS, Greenberg R. Late-life delusional depression. J Affective Disord 1986;11:133–7.
111. Spiker DG, Dealy RS, Hanin I, Weiss JC, Kupfer DJ. Testing delusional depressives with amitriptyline. J Clin Psychiatry 1986; 47:243–6.
112. Holden NL. Late paraphrenia or the paraphrenias? A descriptive study with a 10-year follow-up. Br J Psychiatry 1987;150: 635–9.
113. Smith JM, Baldessarini RJ. Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiatry 1980;37:1368–73.
114. Kane JM, Smith JM. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry 1982;39:473–81.
115. Johnson GFS, Hunt GE, Rey JM. Incidence and severity of tardive dyskinesia increase with age. Arch Gen Psychiatry 1982; 39:486.
116. Mukherjee S, Rosen RM, Cardenas C, Varia V, Olarte S. Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables. Arch Gen Psychiatry 1982;39:466–9.
117. Toenniessen LM, Casey DE, McFarland BH. Tardive dyskinesia in the aged: duration of treatment relationships. Arch Gen Psychiatry 1985;42:278–84.
118. Kretschmar JH. Mianserin and amitriptyline in elderly hospitalized patients with depressive illness: a double-blind trial. Curr Med Res Opin 1980;6(suppl 7):144–51.
119. Soroko FE, Maxwell RA. The pharmacologic basis for therapeutic interest in bupropion. J Clin Psychiatry 1983;44:67–73.
120. Golden RN, James SP, Sherer MA, Rudorfer MV, Sack DA, Potter WZ. Psychoses associated with bupropion treatment. Am J Psychiatry 1985;142:1459–62.
121. Nugent D. A double-blind study of viloxazine (Vivalan) and amitriptyline in depressed geriatric patients. Clin Trials J 1979;16:13–6.
122. Olsen EJ, Bank L, Jarvik LF. Gerovital H-3: a clinical trial as an antidepressant. J Gerontol 1978;33:514–20.
123. Katz MM, Koslow SH, Maas JW, Frazer A, Bowden CL, Casper R, Croughan J, Kocsis J, Redmond E Jr. The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med 1987;17:297–310.
124. Salzman C. Clinical use of antidepressant blood levels and the electrocardiogram. N Engl J Med 1985;313:512–3.
125. Schneider LS. QRS duration in acute overdose of tricyclic antidepressants (letter). N Engl J Med 1986;314:989.
126. Jarvik L., Read SL, Mintz J, Neshkes RE. Pretreatment orthostatic hypotension in geriatric depression: predictor of response to imipramine and doxepin. J Clin Psychopharmacol 1983;3: 368–72.
127. Kukull WA, Koepsell TD, Inui TS, Borson S, Okimoto J, Raskind M., Gale JL. Depression and physical illness among elderly general medical clinic patients. J Affective Disord 1986;10:153–62.
128. Stein EM, Stein S, Linn MW. Geriatric sweet tooth: a problem with tricvclics. J Am Geriatr Soc 1985:33:687–92.
129. Merriam EM, Stein S, Linn MW. Neuroleptic malignant syndrome after imipramine withdrawal. J Clin Psychopharmacol 1987;7:53–4.
130. Burch EA Jr, Downs J. Development of neuroleptic malignant syndrome during simultaneous amoxapine treatment and alprazolam discontinuation. J Clin Psychopharmacol 1987;7:55–6.
131. Bryan GE, Marsh EE, Jabbari B, Gunderson CH. Incidence of seizures in patients receiving tricyclic and tetracyclic antidepressants. Ann Neurol 1983;14:153–9.
132. Robinson DS, Kurtz NM. Question the experts: what is the degree of risk of hepatotoxicity for depressed patients receiving phenelzine therapy? J Clin Psychopharmacol 1987;7:61–2.
133. Janowsky D, Curtis G, Zisook S, Kuhn K, Resovsky K, LeWinter M. Ventricular arrhythmias possibly aggravated by trazodone. Am J Psychiatry 1983;140:796–7.
134. Lippman S, Bedford P, Manshadi M, Mather S. Trazodone cardiotoxicity. Am J Psychiatry 1983;140:1383.
135. Rausch JL, Pavlinac DM, Newman PE. Complete heart block following a single dose of trazodone. Am J Psychiatry 1984;141: 1472–3.
136. Barrnett J, Frances A, Kocsis J, Brown R, Mann J. Peripheral edema associated with trazodone: a report of ten cases. J Clin Psychopharmacol 1985;5: 161–4.
137. Abramowicz M., ed Priapism with trazodone (Desyrel). Med Lett Drugs Ther 1984;26:35.
138. Jones SD. Ejaculatory inhibition with trazodone. J Clin Psychopharmacol 1984;4:279–81.
139. Plotkin DA, Gerson SC, Jarvik LF. Antidepressant drug treatment in the elderly. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:1149–58.